Table 2.
Survival pattern in heart disease–related death NSCLC patients.
| Parameters | Nonimmunotherapy | Immunotherapy | P value bylog rank test |
|---|---|---|---|
| Age | median OS (months) | median OS (months) | |
| 20-69 | 4 | 4 | 0.08 |
| >70 | 4 | 3 | 0.001 |
| Sex | |||
| Male | 4 | 3 | 0.007 |
| Female | 5 | 3 | 0.007 |
| Race | |||
| White | 4 | 3 | 0.004 |
| Black | 5 | 3 | 0.03 |
| Others | 4 | 3 | 0.1 |
| Marital status | |||
| Yes | 4 | 3 | 0.002 |
| Others | 4 | 3 | 0.02 |
| Grade | |||
| I-II | 5 | 3 | 0.06 |
| III-IV | 4 | 2 | 0.006 |
| Others | 4 | 3 | 0.07 |
| Unknown | |||
| Left | 4 | 3 | 0.02 |
| Right | 4 | 3 | 0.002 |
| Missed 1 | |||
| Histology/behave | |||
| Adenocarcinoma | 3 | 2 | 0.2 |
| Squamous cell cancer | 4 | 5 | 0.1 |
| Others | 6 | 3 | 0.0002 |
| Radiation status | |||
| Yes | 6 | 5 | 0.001 |
| No | 2 | 1 | 0.01 |
| Chemotherapy | |||
| Yes | 7 | 5 | 0.003 |
| No | 2 | 1 | 0.006 |
| Insurance status | |||
| Yes | 5 | 3 | 0.003 |
| No/unknown/others | 4 | 2 | 0.01 |